Delsym (dextromethorphan) is a small molecule pharmaceutical. Dextromethorphan was first approved as Delsym on 1982-10-08. It is used to treat cough in the USA. It is known to target sigma non-opioid intracellular receptor 1 and glutamate receptor ionotropic, NMDA 2C.
|Drug Class||Narcotic antagonists/agonists (morphinan derivatives)|